Progenics Pharmaceuticals Inc is an oncology company focused on developing and commercializing targeted medicines and artificial intelligence to treat cancer. Its portfolio includes AZEDRA, 1404, PyL, 1095, PSMA ADC, and EXINI boneBSI. Its partnered products are RELISTOR to treat opioid-induced constipation, and the PRO 140 HIV treatment. Progenics is now a Lantheus company.